Tocilizumab

Dr. Reddy’s Laboratories on Monday said its tocilizumab biosimilar candidate, DRL_TC, for treating rheumatoid arthritis, has successfully met its primary and secondary endpoints in a Phase I study. This Phase I study used an intravenous…

Dr. Reddy’s Laboratories shares gained on Monday in the backdrop of the drugmaker announcing successful completion of a phase-1 study of its proposed biosimilar of tocilizumab for use in the treatment of rheumatoid arthritis. DRL_TC, the…

The World Health Organization said Friday that it had prequalified the arthritis treatment tocilizumab for use in patients hospitalised with severe Covid-19, in a bid to increase access to the pricey drug.The monoclonal antibody, used in…

According to the new guidelines, Remdesivir may be considered only in patients who have completed 10 days since the start of the symptoms and require supplemental oxygen. India…

A biosimilar version of Roche’s Actemra/RoActemra, product will be available by month end. Drugmaker Hetero’s generic version of Tocilizumab has recieved Emergency Use Authorisation (EUA) from the Drugs Controller General of India…